ViTToria Biotherapeutics
Operator of a T-cell therapeutics company intended to offer a therapeutic pipeline targeting clinical needs in oncology and autoimmune disease. The company's technology improves efficacy, enhances saf...
Valuation
$30M
Market implied
Share Price
N/A
Total Raised
$35M
Last Round
N/A